Tildrakizumab Significantly Improves Skin Symptoms in Moderate-to-Severe Psoriasis
At week 52, investigators noted an overall improvement of 93% in PASI scores from baseline.
Source: hcplive.com
Body Surface Area News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Body Surface Area. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Body Surface Area Today - Breaking & Trending Today
Ruxolitinib Cream Improves Itch, Sleep, Skin Pain in Children with Atopic Dermatitis
A secondary analysis from TRuE-AD3 shows ruxolitinib cream significantly benefits pediatric atopic dermatitis patient-reported outcomes.
Source: hcplive.com
Plaque Psoriasis: Pharmacogenetic Biomarkers May Predict Response to Secukinumab
Pharmacogenetic biomarkers may likely predict response to secukinumab in patients with plaque psoriasis, according to study findings.
Source: clinicaladvisor.com
A GVHD Clinical Scenario
Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz review a clinical scenario of chronic GVHD post-allogeneic transplant. They explore treatment options and emphasize shared decision-making, considering patient preferences and therapeutic benefits.
Source: onclive.com
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
/PRNewswire/ -- Johnson & Johnson today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial results for...
Source: prnewswire.com